Kunte, S., Braman, N., Bera, K., Leo, P., Abraham, J., Montero, A., & Madabhushi, A.(2020).Radiomics risk score (RRS) on CT to predict survival and response to CDK 4/6 inhibitors in hormone receptor (HR) positive metastatic breast cancer (MBC)..Journal of Clinical Oncology,38(15_suppl),e13041-e13041.
